UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004255
Receipt No. R000005071
Scientific Title Phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment
Date of disclosure of the study information 2010/09/24
Last modified on 2014/03/22 21:13:12

No. Disposal Last modified on Item of update
1 Insert 2010/09/22 19:52:01
2 Update 2010/11/06 10:27:56 Recruitment status
Anticipated trial start date
3 Update 2011/03/22 18:02:04 Institutions
4 Update 2011/09/22 19:26:24 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
5 Update 2012/10/01 21:00:34 Recruitment status
6 Update 2012/10/01 21:02:59 Institutions
7 Update 2013/09/22 11:37:13 Email
8 Update 2013/09/22 11:37:51 Publication of results
9 Update 2014/03/22 21:13:12 Recruitment status


Contact us.